FDA Will Rev GMP Inspections Of Medium Supplement Firms, After A Pause

Medium-sized dietary supplement firms should not be fooled if FDA gets off to a slow start inspecting for good manufacturing practices compliance, but should expect a marked uptick in the agency's volume of inspections

More from Archive

More from Pink Sheet